Low molecular weight biotechnological chondroitin 6-sulfate for osteoarthritis prevention

摘要

Patent Summary: "Low molecular weight biotechnological chondroitin 6-sulfate for prevention of osteoarthritis". The present invention relates to a low molecular weight (1000 to 5000 daltons) chondroitin sulfate (cs) produced by chemical sulfation and subsequent depolymerization of an unsulfated chondroitin framework obtained by biotechnology techniques. The described dog is substantially monosulfated, especially at position 6, with very little sulfation at position 4 and with a similar mono / disaccharide ratio and charge density to those of natural dog. said biotechnological chondroitin 6-sulfate (c6s) is useful in the treatment and prevention of osteoarthritis and in acute and chronic inflammatory processes.